These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 20571866)

  • 1. Mitochondrial medicine: to a new era of gene therapy for mitochondrial DNA mutations.
    Cwerman-Thibault H; Sahel JA; Corral-Debrinski M
    J Inherit Metab Dis; 2011 Apr; 34(2):327-44. PubMed ID: 20571866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Targeting allotopic material to the mitochondrial compartment: new tools for better understanding mitochondrial physiology and prospect for therapy].
    Rustin P; T Jacobs H; Dietrich A; N Lightowlers R; Tarassov I; Corral-Debrinski M
    Med Sci (Paris); 2007 May; 23(5):519-25. PubMed ID: 17502069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for treating disorders of the mitochondrial genome.
    Smith PM; Ross GF; Taylor RW; Turnbull DM; Lightowlers RN
    Biochim Biophys Acta; 2004 Dec; 1659(2-3):232-9. PubMed ID: 15576056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches and limitations to gene therapy for mitochondrial diseases.
    Owen R; Flotte TR
    Antioxid Redox Signal; 2001 Jun; 3(3):451-60. PubMed ID: 11491656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of mitochondrial gene replacement therapy.
    Khan SM; Bennett JP
    J Bioenerg Biomembr; 2004 Aug; 36(4):387-93. PubMed ID: 15377877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons from mitochondrial DNA mutations.
    DiMauro S
    Semin Cell Dev Biol; 2001 Dec; 12(6):397-405. PubMed ID: 11735374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress and prospects: gene therapy for mitochondrial DNA disease.
    Kyriakouli DS; Boesch P; Taylor RW; Lightowlers RN
    Gene Ther; 2008 Jul; 15(14):1017-23. PubMed ID: 18496570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current progress with mammalian models of mitochondrial DNA disease.
    Stewart JB
    J Inherit Metab Dis; 2021 Mar; 44(2):325-342. PubMed ID: 33099782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for the mitochondrial genome: Purging mutations, pacifying ailments.
    Aravintha Siva M; Mahalakshmi R; Bhakta-Guha D; Guha G
    Mitochondrion; 2019 May; 46():195-208. PubMed ID: 29890303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial diseases: therapeutic approaches.
    DiMauro S; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):125-37. PubMed ID: 17486439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial genetic medicine.
    Wallace DC
    Nat Genet; 2018 Dec; 50(12):1642-1649. PubMed ID: 30374071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial disorders and the eye.
    Schrier SA; Falk MJ
    Curr Opin Ophthalmol; 2011 Sep; 22(5):325-31. PubMed ID: 21730846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for the treatment of mitochondrial DNA disorders.
    Taylor RW
    Expert Opin Biol Ther; 2005 Feb; 5(2):183-94. PubMed ID: 15757380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concise Review: Heteroplasmic Mitochondrial DNA Mutations and Mitochondrial Diseases: Toward iPSC-Based Disease Modeling, Drug Discovery, and Regenerative Therapeutics.
    Hatakeyama H; Goto Y
    Stem Cells; 2016 Apr; 34(4):801-8. PubMed ID: 26850516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of molecular genetics and research progress on mitochondrial diseases].
    Zhang M; Si Y; Zhao J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):717-25. PubMed ID: 27577231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic Mitochondria DNA Mutations: Current Detection Tools and Interventions.
    Mustafa MF; Fakurazi S; Abdullah MA; Maniam S
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32059522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo mitochondrial base editing via adeno-associated viral delivery to mouse post-mitotic tissue.
    Silva-Pinheiro P; Nash PA; Van Haute L; Mutti CD; Turner K; Minczuk M
    Nat Commun; 2022 Feb; 13(1):750. PubMed ID: 35136065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MITO-Porter; a cutting-edge technology for mitochondrial gene therapy].
    Furukawa R; Yamada Y; Harashima H
    Yakugaku Zasshi; 2012; 132(12):1389-98. PubMed ID: 23208046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mitochondrial DNA mutations and related human diseases].
    Chen G; Du WD; Cao HM
    Yi Chuan; 2007 Nov; 29(11):1299-1308. PubMed ID: 17989055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dynamics and aging: Mitochondrial interaction preventing individuals from expression of respiratory deficiency caused by mutant mtDNA.
    Sato A; Nakada K; Hayashi J
    Biochim Biophys Acta; 2006; 1763(5-6):473-81. PubMed ID: 16624428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.